Forest Laboratories, Inc.

Almirall and Forest Laboratories Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel Long-Acting Anticholinergic for the Treatment for COPD

Toronto (ots/PRNewswire) - - Data Presented at the 2008 International Conference of the American Thoracic Society Laboratorios Almirall, S.A. and Forest Laboratories, Inc. today presented results from four clinical trials assessing the efficacy and safety of aclidinium bromide, an investigational ...